Neogen Chemicals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Haridas Kanani

Chief executive officer

₹8.5m

Total compensation

CEO salary percentage	90.8%
CEO tenure	35.1yrs
CEO ownership	49.3%
Management average tenure	4.4yrs
Board average tenure	9.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Haridas Kanani's remuneration changed compared to Neogen Chemicals's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	₹330m
Sep 30 2023	n/a	n/a	₹467m
Jun 30 2023	n/a	n/a	₹486m
Mar 31 2023	₹8m	₹8m	₹500m
Dec 31 2022	n/a	n/a	₹513m
Sep 30 2022	n/a	n/a	₹471m
Jun 30 2022	n/a	n/a	₹484m
Mar 31 2022	₹6m	₹6m	₹446m
Dec 31 2021	n/a	n/a	₹383m
Sep 30 2021	n/a	n/a	₹364m
Jun 30 2021	n/a	n/a	₹326m
Mar 31 2021	₹6m	₹6m	₹313m
Dec 31 2020	n/a	n/a	₹293m
Sep 30 2020	n/a	n/a	₹290m
Jun 30 2020	n/a	n/a	₹293m
Mar 31 2020	₹5m	₹5m	₹287m
Dec 31 2019	n/a	n/a	₹301m
Sep 30 2019	n/a	n/a	₹262m
Jun 30 2019	n/a	n/a	₹225m
Mar 31 2019	₹5m	₹5m	₹209m
Mar 31 2018	₹3m	₹3m	₹110m

Compensation vs Market: Haridas's total compensation ($USD101.60K) is below average for companies of similar size in the Indian market ($USD274.99K).

Compensation vs Earnings: Haridas's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Haridas Kanani (77 yo)

35.1yrs

Tenure

₹8,480,000

Compensation

Mr. Haridas Thakarshi Kanani, B.Tech (Chem), M.I.I.Ch.E. serves as the Chairman and Managing Director of Neogen Chemicals Limited and serves as its Director since March 07, 1989. He oversees the manufactur...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Haridas Kanani	Chairman & MD	no data	₹8.48m	49.29% ₹ 20.0b
Harin Kanani	MD & Executive Director	6.8yrs	₹8.26m	7.59% ₹ 3.1b
Shyamsunder Upadhyay	Whole Time Director	no data	₹8.04m	0.00030% ₹ 121.5k
Ketan Vyas	Chief Financial Officer	3.5yrs	no data	no data
Unnati Kanani	Company Secretary & Compliance Officer	4.4yrs	₹690.56k	no data

4.4yrs

Average Tenure

58.5yo

Average Age

Experienced Management: 542665's management team is considered experienced (4.4 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Haridas Kanani	Chairman & MD	35.1yrs	₹8.48m	49.29% ₹ 20.0b
Harin Kanani	MD & Executive Director	10.8yrs	₹8.26m	7.59% ₹ 3.1b
Shyamsunder Upadhyay	Whole Time Director	8.8yrs	₹8.04m	0.00030% ₹ 121.5k
Anurag Surana	Non Executive & Non-Independent Director	6.9yrs	no data	0.85% ₹ 345.4m
Sanjay Mehta	Independent Non-Executive Director	11.6yrs	₹300.00k	0.0098% ₹ 4.0m
Hitesh Reshamwala	Independent Non-Executive Director	9.6yrs	₹300.00k	0.00014% ₹ 56.7k
Ranjan Malik	Independent Non-Executive Director	5.5yrs	₹200.00k	no data
Avi Sabavala	Independent Non-Executive Woman Director	5.5yrs	₹200.00k	no data

9.2yrs

Average Tenure

65.5yo

Average Age

Experienced Board: 542665's board of directors are considered experienced (9.2 years average tenure).

Neogen Chemicals Management

Management criteria checks 3/4

Key information

Recent management updates

Neogen Chemicals Limited, Annual General Meeting, Sep 05, 2023

Insufficient new directors

Neogen Chemicals Limited, Annual General Meeting, Sep 28, 2022

Insufficient new directors

Insufficient new directors

Insider recently sold ₹7.8m worth of stock

Recent updates

Neogen Chemicals Limited to Report Q4, 2024 Results on Apr 30, 2024

Price target decreased by 7.9% to ₹1,644

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Neogen Chemicals Limited to Report Q3, 2024 Results on Feb 09, 2024

New minor risk - Shareholder dilution

Neogen Chemicals Limited to Report Q2, 2024 Results on Nov 08, 2023

Neogen Chemicals Limited announced that it expects to receive INR 2.529996897 billion in funding from SBI Funds Management Limited, Acorn Asset Management Ltd, Invesco India Smallcap Fund and other investors

Upcoming dividend of ₹3.00 per share at 0.2% yield

First quarter 2024 earnings released: EPS: ₹3.92 (vs ₹4.45 in 1Q 2023)

Neogen Chemicals Limited, Annual General Meeting, Sep 05, 2023

Neogen Chemicals Limited to Report Q1, 2024 Results on Aug 05, 2023

Full year 2023 earnings released: EPS: ₹20.03 (vs ₹17.90 in FY 2022)

Neogen Chemicals Limited Recommends Final Dividend for the Financial Year 2022-23

Neogen Chemicals Limited to Report Q4, 2023 Results on May 13, 2023

Neogen Chemicals Limited (NSEI:NEOGEN) completed the acquisition of BuLi Chemicals India Private Limited from Livent Corporation (NYSE:LTHM) and Livent USA Corp.

Investor sentiment improves as stock rises 26%

Third quarter 2023 earnings released: EPS: ₹5.89 (vs ₹4.49 in 3Q 2022)

Neogen Chemicals Limited to Report Q3, 2023 Results on Feb 11, 2023

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹3.95 (vs ₹4.79 in 2Q 2022)

Neogen Chemicals Limited to Report Q2, 2023 Results on Nov 05, 2022

Upcoming dividend of ₹2.75 per share

First quarter 2023 earnings released: EPS: ₹4.45 (vs ₹3.15 in 1Q 2022)

Neogen Chemicals Limited, Annual General Meeting, Sep 28, 2022

Neogen Chemicals Limited to Report Q1, 2023 Results on Aug 06, 2022

Neogen Chemicals Limited Announces Final Dividend for 2021

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Neogen Chemicals Limited to Report Q4, 2022 Results on May 14, 2022

Insufficient new directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Neogen Chemicals Limited announced that it expects to receive INR 2.249995985 billion in funding

Insufficient new directors

Second quarter 2022 earnings released: EPS ₹4.79 (vs ₹3.16 in 2Q 2021)

Price target increased to ₹1,154

Upcoming dividend of ₹2.25 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS ₹3.15 (vs ₹2.62 in 1Q 2021)

Price target increased to ₹989

Full year 2021 earnings released: EPS ₹13.45 (vs ₹12.28 in FY 2020)

Neogen Chemicals Limited Recommends Final Dividend for the Financial Year 2020-21

Investor sentiment improved over the past week

New 90-day high: ₹906

Third quarter 2021 earnings released: EPS ₹3.66 (vs ₹3.46 in 3Q 2020)

Revenue misses expectations

Neogen Chemicals Limited to Report Q3, 2021 Results on Feb 13, 2021

Insider recently sold ₹7.8m worth of stock

Market bids up stock over the past week

New 90-day high: ₹707

New 90-day low: ₹611

Second quarter 2021 earnings released: EPS ₹3.16

Neogen Chemicals Limited to Report Q2, 2021 Results on Nov 07, 2020

Neogen Chemicals Limited Approves the Appointment of Mr. Ketan Vyas as the Chief Financial Officer and Whole Time Key Managerial Personnel of the Company

Upcoming Dividend of ₹2.00 Per Share

New 90-day high - ₹681

First quarter earnings released

New 90-day high - ₹593

Neogen Chemicals Limited to Report Q1, 2021 Results on Aug 08, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age